- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.05. | BioNTech, gearing up for cancer drug approval filing, works to diversify supply base | ||
| 02.05. | AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion | ||
| 02.05. | BMS scales back at former Novartis plant, shifting cell therapy vector production to MA | ||
| 02.05. | Almirall, Biofrontera encourage sun protection in actinic keratosis social media challenge | ||
| 02.05. | Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row | ||
| 02.05. | As Amgen's trio of Horizon drugs disappoints, execs urge analysts to give them more time | ||
| 02.05. | Regulatory tracker: AbbVie's Rinvoq scores 9th FDA nod, this time in GCA | ||
| 30.04. | AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap | ||
| 30.04. | Sanofi nets €10B from Opella sale, eyes more 'bolt-on' deals | ||
| 30.04. | As vaccine sales slip, GSK touts 'mitigation options' for potential drug tariffs | ||
| 30.04. | J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy | ||
| 30.04. | Charles Barkley boards Ro's GLP-1 ad push, signing up to take a 2nd shot at weight loss | ||
| 29.04. | Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe | ||
| 29.04. | AstraZeneca's highly touted Truqap flunks another phase 3 trial | ||
| 29.04. | Bipartisan House lawmakers try again to cut tax breaks for DTC drug ads | ||
| 29.04. | Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection | ||
| 29.04. | Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B | ||
| 29.04. | Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy | ||
| 29.04. | As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tariffs | ||
| 29.04. | Merck begins construction on $1B Keytruda manufacturing facility in Delaware | ||
| 29.04. | Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease | ||
| 29.04. | Bayer gets industry discredit ruling overturned after accusation of 'warming the market' for Eylea launch | ||
| 28.04. | Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch' | ||
| 28.04. | PCI's expansion tear rolls on with acquisition of fill-finish CDMO Ajinomoto Althea | ||
| 28.04. | Delivering Hope: Building a Network to Deliver Radioligand Therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .